Sr Scientist till iCoat Medical

iCoat Medical is a Swedish pharmaceutical company focused on developing products to improve the outcome of organ transplantations and help patients across the world, who are in need of a new organ. The innovation is based on a coating treatment of donor organs prior to transplantation, which makes them less recognisable for the innate immune system of the patient.

The company is now on an exciting journey towards commercialisation of its products and is at a stage of high intensity and progress and therefore need to reinforce the team with a senior scientist. Are you an experienced scientist in the field of immunochemistry or biochemistry with a strong industry track record and have passion for hands-on lab work? Then this is the role for you! You will be working with some of the world's leading scientists within innate immunology within a company with potential to transform the transplantation market.

About the role

The Sr Scientist will be part of the Science team in Uppsala, which consists of seven coworkers. You will spend the majority of your time working hands-on in the lab and drive the development of the company’s product candidates forward while having a frequent exposure to all parts of the company’s operations. You will work with different biochemical, biophysical and immunological techniques, including protein separation and purification methods, ELISA, flowcytometry, and different chemical analysis methods.

As Sr Scientist in the science team your main responsibilities include:

• Be the operational lead on scientific experiments and analyses and cooperate daily with the company’s CTO, Head of CMC, and the rest of the scientific team
• Continue to develop and optimise the company’s technology platform
• Coordinate the overall drug development in collaboration with the head of CMC
• Establish an industry knowledge of iCoat Medical in the industry by contributing to articles, publications and conferences
• Develop industry best practices and industry standards in the company’s operations
• Improve and expand scientific documentation, reports and pre-clinical literature

About You

We believe that you will contribute with a deep understanding of scientific work and preferably with academic and/or industrial experience from working with the innate immune system (contact-, coagulation- and complement systems).

As a person you have good scientific practice, and you are well organised. You thrive in a lab-setting, and you can work independently and autonomously, however, managing smaller teams of junior scientists is also required. You have a proven track record of being a doer, i.e., achieving operational results. You need to have an entrepreneurial mindset and excited to join a small but ambitious company. Experience from clinical trials in small organisations is highly regarded.

Qualifications and key experience

In order to be successful in the role you need to fulfil the following qualifications:

• Minimum PhD degree in immunochemistry and/or biochemistry
• Strong track record of independent lab work
• 5-10 years’ experience from leading pharmaceutical companies
• Strong capabilities in organising and structuring his/her individual work
• Compiling, presenting and documenting analyses and results on an industry-level
• Previous experience in leading and managing small teams of junior scientists
• Comfortable with working with colleagues from a broad range of professional backgrounds as well as with distributed teams – we have operations across Sweden
• Fluent in English, preferably also in Swedish

Interested?

For this recruitment process, iCoat Medical is working with Mpya Sci & Tech. Please submit your application no later than the 19th of December. Contact Talent Advisor Emelie Gralberg for any further questions, +46728886705, emelie.gralberg@mpyascitech.com

About ICoat Medical

iCoat Medical’s business idea is to develop and market medicine for successful transplants of vital organs while enabling a greater availability of organs for transplantation. iCoat Medical’s product candidate, TUM012, has the potential to transform the transplantation market. The product is based on 25 years’ research and development in collaboration with leading academic institutes. Vast preclinical studies show that TUM012 has the potential to improve the kidney’s function following transplantation. The organisation includes surgeons and scientists with expertise in all phases of research and development as well as an experienced commercial team. TUM012 will initially be used for kidneys but the plan is that the product will be used also in other organ transplants, such as heart. The transplantation market is large and non-cyclical, and the company estimates that more than 200 000 transplants will be carried in 2025, which is when the company’s product is expected to be ready for commercialisation.

Vision

iCoat Medical’s products will be used in all surgeries across the world where ischemia reperfusion injury constitutes a problem.

Mission

iCoat Medical will improve the outcome of organ transplants to the benefit of the patient, for increased availability of organs for transplants and reduced societal cost.